| News & Announcements | 1/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Products | | | | | | 1/4/2021 | | |
| News & Announcements | Telemedicine Services for Independence Commercial Members (Updated January 4, 2021) | | | | | | 1/4/2021 | | |
| News & Announcements | Coverage of the COVID-19 Vaccination for Independence Members (Updated January 19, 2021) | | | | | | 1/19/2021 | | |
| Notifications | Patient Lifts | 05.00.42h | 1/15/2021 1:00 PM | 2/15/2021 | | | 1/15/2021 | Coverage and/or Reimbursement Position | |
| Notifications | Ankle-Foot/Knee-Ankle-Foot Orthoses | 05.00.39p | 1/15/2021 2:00 PM | 2/15/2021 | | | 1/15/2021 | Coverage and/or Reimbursement Position;Medical Coding | |
| New Policies | Artificial Intervertebral Lumbar Disc Insertion | 11.15.31 | 10/12/2020 2:00 PM | 1/10/2021 | | | 1/8/2021 | This is a New Policy. | |
| New Policies | Osteogenic Stimulators (non-invasive, invasive/semi-invasive, electrical and ultrasound) | 05.00.81 | | 1/10/2021 | | | 1/8/2021 | This is a New Policy. | |
| New Policies | Reimbursement for the Administration of Drugs, Substances, and/or Biologic Agents | 00.10.43 | 10/19/2020 3:00 PM | 1/18/2021 | | | 1/18/2021 | This is a New Policy. | |
| Updated Policies | Coagulation Factors | 08.00.92ac | 9/28/2020 12:00 AM | 1/1/2021 | | | 1/1/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | |
| Updated Policies | eviCore Lab Management (Independence) | 06.02.52s | 12/1/2020 12:00 AM | 1/1/2021 | | | 1/1/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | |
| Updated Policies | Pemetrexed (Alimta®) | 08.00.87h | | 1/4/2021 | | | 1/4/2021 | Medical Necessity Criteria | |
| Updated Policies | Ado-Trastuzumab Emtansine (Kadcyla®) | 08.01.11f | | 1/4/2021 | | | 1/4/2021 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | |
| Updated Policies | Reporting Requirements for Drugs and Biologics | 00.01.49d | | 1/4/2021 | | | 1/4/2021 | Medical Coding;General Description, Guidelines, or Informational Update | |
| Updated Policies | Facility Reporting of Observation Services | 00.01.19e | | 1/4/2021 | | | 1/4/2021 | Coverage and/or Reimbursement Position;General Description, Guidelines, or Informational Update | |
| Updated Policies | Gender Affirming Interventions | 11.09.02i | | 1/4/2021 | | | 1/4/2021 | General Description, Guidelines, or Informational Update | |
| Updated Policies | Home Health Care Services | 02.01.01e | | 1/4/2021 | | | 1/4/2021 | General Description, Guidelines, or Informational Update | |
| Updated Policies | Personalized Vaccines (e.g. Provenge®) | 08.00.95e | | 1/4/2021 | | | 1/4/2021 | Medical Necessity Criteria | |
| Updated Policies | Alpha 1-Antitrypsin Therapy (e.g., Prolastin-C®, Aralast NP®, Glassia®, Zemaira®) | 08.00.91e | | 1/4/2021 | | | 1/4/2021 | Medical Necessity Criteria | |
| Updated Policies | Care Management and Care Planning Services | 00.01.59h | | 1/4/2021 | | | 1/4/2021 | Medical Necessity Criteria | |
| Updated Policies | Percutaneous Vertebroplasty, Kyphoplasty and Sacroplasty (Independence Administrators) | 11.14.10s | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Musculoskeletal Services (Independence) | 00.01.66c | 10/12/2020 2:00 PM | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position;Medical Coding | |
| Updated Policies | Artificial Intervertebral Cervical Disc Insertion (Independence Administrators) | 11.14.19p | 10/12/2020 9:00 AM | 1/10/2021 | | | 1/8/2021 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | |
| Updated Policies | Meniscal Allograft Transplantation and Meniscal Implants (Independence Administrators) | 11.14.03h | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Osteochondral Allograft Transplantation (Independence Administrators) | 11.14.12f | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Osteochondral Autograft Transplantation (Independence Administrators) | 11.14.09h | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Surgical Treatment of Femoroacetabular Impingement (Independence Administrators) | 11.14.23d | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Spinal Discectomy (Independence Administrators) | 11.14.29g | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Denervation of the Spinal Nerves for Chronic Pain (Independence Administrators) | 11.15.09o | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Spinal Cord Ganglion and Dorsal Root Ganglion Stimulation (Independence Administrators) | 11.15.01x | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Spinal Fusion (Independence Administrators) | 11.14.27e | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Spinal Laminectomy (Independence Administrators) | 11.14.28d | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Autologous Chondrocyte Implantation (ACI) and Other Cell-based Treatments of Focal Articular Cartilage Lesions (Independence Administrators) | 11.14.06j | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Epidural, Paravertebral Facet, and Sacroiliac Joint Injections for Spinal Pain Management (Independence Administrators) | 11.15.23j | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Electrical Bone Growth Stimulation and Low-Intensity Ultrasound Accelerated Fracture Healing System (Independence Administrators) | 05.00.09i | | 1/10/2021 | | | 1/8/2021 | Coverage and/or Reimbursement Position | |
| Updated Policies | Pertuzumab (Perjeta®) | 08.01.07g | | 1/18/2021 | | | 1/18/2021 | Medical Necessity Criteria;Medical Coding | |
| Updated Policies | Blepharoplasty, Repair of Blepharoptosis, Repair of Brow Ptosis, and Canthoplasty/Canthopexy | 11.05.02j | | 1/18/2021 | | | 1/18/2021 | Medical Necessity Criteria;Medical Coding | |
| Updated Policies | Mogamulizumab-kpkc (Poteligeo®) | 08.01.52c | | 1/18/2021 | | | 1/18/2021 | Medical Necessity Criteria | |
| Updated Policies | Reimbursement for an Intraocular Lens | 11.05.10c | 10/20/2020 2:00 PM | 1/18/2021 | | | 1/18/2021 | Medical Coding | |
| Updated Policies | Always Bundled Procedure Codes | 00.01.52k | | 1/18/2021 | | | 1/18/2021 | Coverage and/or Reimbursement Position;Medical Coding;General Description, Guidelines, or Informational Update | |
| Updated Policies | Evaluation and Management of Autism Spectrum Disorder (ASD) | 07.03.07v | | 1/18/2021 | | | 1/18/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | |
| Updated Policies | Asparaginase Erwinia Chrysanthemi (Erwinaze®) | 08.01.35c | | 1/18/2021 | | | 1/18/2021 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | |
| Updated Policies | Bevacizumab (Avastin®) and Related Biosimilars For Oncologic Use | 08.00.66o | | 1/18/2021 | | | 1/18/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | |
| Updated Policies | Durable Medical Equipment (DME) Not Subject to a Rental to Purchase Maximum | 05.00.48k | | 1/18/2021 | | | 1/18/2021 | General Description, Guidelines, or Informational Update | |
| Updated Policies | Private Duty Nursing | 02.01.02d | | 1/18/2021 | | | 1/18/2021 | Medical Necessity Criteria | |
| Coding Update | Inebilizumab-cdon (Uplizna) | 08.01.68a | | 1/4/2021 | | | 1/4/2021 | | |
| Coding Update | Genetic Testing for Congenital Long QT Syndrome (Independence Administrators) | 06.02.31g | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Genetic Testing for Inherited Susceptibility to Colon Cancer and Microsatellite Instability Testing (Familial Adenomatous Polyposis and Lynch Syndrome) (Independence Administrators) | 06.02.10r | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Daratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro™) | 08.01.29h | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Lurbinectedin (Zepzelca) | 08.01.67a | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG) | 08.00.13aa | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Pegfilgrastim (Neulasta®) and Related Biosimilars | 08.01.32d | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campus | 00.10.39n | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Multiple Procedure Payment Reduction (MPPR) on Certain Diagnostic Services | 00.01.60e | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Radiologic Guidance and/or Supervision and Interpretation of a Procedure | 00.10.36s | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | STAT Laboratory Tests Performed in the Outpatient Hospital Setting for Health Maintenance Organization (HMO) and Point of Service (POS) Products | 00.01.41c | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Sacituzumab govitecan-hziy (TrodelvyTM) | 08.01.60b | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Belantamab mafodotin-blmf (Blenrep) | 08.01.70a | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Direct Access to Obstetrics/Gynecology (OB/GYN) Services | 00.09.01h | | 1/1/2021 | | | 1/4/2021 | | |
| Coding Update | Reimbursement for Radiopharmaceutical Agents for Professional Providers | 09.00.32v | | 1/1/2021 | | | 1/8/2021 | | |
| Coding Update | Multiple Surgery Payment Reduction | 11.00.10x | | 1/1/2021 | | | 1/11/2021 | | |
| Coding Update | Modifier 25: Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service | 03.00.06t | | 1/1/2021 | | | 1/11/2021 | | |
| Coding Update | PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative Services | 00.01.25ba | | 1/1/2021 | | | 1/11/2021 | | |
| Coding Update | Modifier 50: Bilateral Procedure | 03.00.05o | | 1/1/2021 | | | 1/13/2021 | | |
| Coding Update | Modifiers 26 (Professional Component) and TC (Technical Component) | 03.00.20l | | 1/1/2021 | | | 1/13/2021 | | |
| Coding Update | Services Paid Above Capitation for Health Maintenance Organization (HMO) and Health Maintenance Organization Point-of-Service (HMO-POS) Primary Care Providers | 00.10.01ad | | 1/1/2021 | | | 1/13/2021 | | |
| Coding Update | Diagnostic Radiology Services Included in Capitation | 00.03.02ab | | 1/1/2021 | | | 1/15/2021 | | |
| Coding Update | Modifier 66: Surgical Team | 00.10.17k | | 1/1/2021 | | | 1/15/2021 | | |
| Coding Update | Modifier 62: Two Surgeons | 00.10.11o | | 1/1/2021 | | | 1/15/2021 | | |
| Coding Update | Laboratory Services for Members Enrolled in Health Maintenance Organization (HMO) or Health Maintenance Organization Point-of-Service (HMO-POS) Products | 00.03.07ab | | 1/1/2021 | | | 1/15/2021 | | |
